ProteinQure
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$19.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ProteinQure is a biotechnology company that has developed a computational platform for the design of peptide-based therapeutics using quantum computing, artificial intelligence, and molecular dynamics simulations.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProteinQure Comparables
Compare ProteinQure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unnatural Products | 88% | |
| Pepticom | 84% | |
| Syneron Bio | 82% |
ProteinQure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Grant | Apr 7, 2026 | ||||
| Series A | May 28, 2025 | ||||
| Grant | Jan 21, 2025 | ||||
| Grant | Feb 22, 2024 | ||||
Seed | Jul 25, 2019 |
Key People
Founding team and executive leadership
ProteinQure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kensington Capital Partners | Series A |
| Global Founders Capital | Seed |
| Federal Economic Development Agency for Southern Ontario | Grant |
| Inovia Capital | Seed |
| Heron Rock Fund | Series A |
| Kensington Capital Partners | Series A |
| FedDev Ontario | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$1.31M grant from Federal Economic Development Agency for Southern Ontario
- Apr 7, 2026
$1.86M grant received
ProteinQure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ProteinQure's valuation, stock price, and market status.
Is ProteinQure a public or private company?
ProteinQure is a private company.
What is the current stock price of ProteinQure?
ProteinQure is a private company, so its shares have no public market price. Caplight tracks ProteinQure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProteinQure worth (valuation)?
Valuation information for ProteinQure is not publicly available.
Can I buy ProteinQure stock?
ProteinQure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProteinQure's last funding round?
ProteinQure's most recent funding round was Grant on May 27, 2026.
Who are the main investors in ProteinQure?
Key investors in ProteinQure include Heron Rock Fund, Felicis Ventures.
Will ProteinQure IPO soon?
No public IPO plans have been announced for ProteinQure.
How can I track ProteinQure secondary market activity?
Caplight tracks bids, offers, and trades in ProteinQure's shares on secondary markets.